| 01/06/23 | 15:00:03 | 1 Jun 2023 | | Issue of Equity and Total Voting Rights |
| 19/05/23 | 07:00:04 | 19 May 2023 | | London Calling Technology Update |
| 12/05/23 | 13:30:00 | 12 May 2023 | | Holding(s) in Company |
| 12/05/23 | 08:35:41 | 12 May 2023 | | Next step of PathoQuest strategic collaboration |
| 11/05/23 | 16:00:01 | 11 May 2023 | | Share Incentive Plan - Director/PDMR Shareholding |
| 04/05/23 | 16:30:01 | 4 May 2023 | | Director/PDMR Notification |
| 02/05/23 | 15:00:01 | 2 May 2023 | | Issue of Equity and Total Voting Rights |
| 26/04/23 | 07:00:11 | 26 Apr 2023 | | Publication of Annual Report and Notice of AGM |
| 17/04/23 | 07:00:07 | 17 Apr 2023 | | New infectious disease partnership with bioMerieux |
| 13/04/23 | 18:00:01 | 13 Apr 2023 | | Director/PDMR Shareholding |
| 12/04/23 | 16:00:01 | 12 Apr 2023 | | Share Incentive Plan - Director/PDMR Shareholding |
| 12/04/23 | 16:00:01 | 12 Apr 2023 | | LTIP and DBP; Director/PDMR Notification |
| 11/04/23 | 07:00:10 | 11 Apr 2023 | | NIH Alzheimers study shows scaled, accurate data |
| 06/04/23 | 16:00:01 | 6 Apr 2023 | | Block listing Interim Review |
| 03/04/23 | 15:30:01 | 3 Apr 2023 | | Issue of Equity and Total Voting Rights |
| 31/03/23 | 07:00:09 | 31 Mar 2023 | | NIHR, Oxford Nanopore announce new health study |
| 21/03/23 | 07:00:23 | 21 Mar 2023 | | Final results for the year ended 31 December 2022 |
| 13/03/23 | 16:00:02 | 13 Mar 2023 | | Share Incentive Plan - Director/PDMR Shareholding |
| 09/03/23 | 07:00:09 | 9 Mar 2023 | | Notice of Results |
| 01/03/23 | 15:30:01 | 1 Mar 2023 | | Issue of Equity and Total Voting Rights |
| 27/02/23 | 18:00:01 | 27 Feb 2023 | | Changes to Director Roles and Responsibilities |
| 13/02/23 | 17:00:01 | 13 Feb 2023 | | Share Incentive Plan - Director/PDMR Shareholding |
| 01/02/23 | 16:30:01 | 1 Feb 2023 | | Total Voting Rights and Issue of Equity |
| 17/01/23 | 07:00:04 | 17 Jan 2023 | | Trading update |
| 13/01/23 | 15:30:00 | 13 Jan 2023 | | Director/PDMR Shareholding (ESPP) |
| 11/01/23 | 16:00:01 | 11 Jan 2023 | | Share Incentive Plan - Director/PDMR Shareholding |
| 04/01/23 | 17:30:01 | 4 Jan 2023 | | Director/PDMR Shareholding (ESPP) |
| 03/01/23 | 17:00:01 | 3 Jan 2023 | | Issue of equity and Total Voting Rights |
| 28/12/22 | 15:00:05 | 28 Dec 2022 | | Holding(s) in Company |
| 23/12/22 | 12:00:01 | 23 Dec 2022 | | Holding(s) in Company |
| 13/12/22 | 16:50:38 | 13 Dec 2022 | | Share Incentive Plan - Director/PDMR Shareholding |
| 01/12/22 | 15:00:04 | 1 Dec 2022 | | Issue of Equity and Total Voting Rights |
| 11/11/22 | 16:30:01 | 11 Nov 2022 | | Share Incentive Plan - Director/PDMR Shareholding |
| 11/11/22 | 16:30:01 | 11 Nov 2022 | | Director/PDMR Shareholding |
| 01/11/22 | 17:00:01 | 1 Nov 2022 | | Issue of Equity and Total Voting Rights |
| 11/10/22 | 16:00:00 | 11 Oct 2022 | | Share Incentive Plan - Director/PDMR Shareholding |
| 10/10/22 | 12:00:05 | 10 Oct 2022 | | Director/PDMR Shareholding |
| 06/10/22 | 17:30:01 | 6 Oct 2022 | | Block listing Interim Review |
| 03/10/22 | 17:00:01 | 3 Oct 2022 | | Issue of Equity and Total Voting Rights |
| 29/09/22 | 09:00:03 | 29 Sept 2022 | | Director/PDMR Shareholding |
| 14/09/22 | 11:00:05 | 14 Sept 2022 | | Director/PDMR Shareholding |
| 13/09/22 | 17:00:03 | 13 Sept 2022 | | Share Incentive Plan - Director/PDMR Shareholding |
| 13/09/22 | 07:00:11 | 13 Sept 2022 | | Interim results for the period ended 30 June 2022 |
| 12/09/22 | 16:30:05 | 12 Sept 2022 | | Oxford Nanopore to present at upcoming conferences |
| 01/09/22 | 18:30:05 | 1 Sept 2022 | | Issue of Equity and Total Voting Rights |
| 24/08/22 | 07:00:06 | 24 Aug 2022 | | Notice of Results |
| 11/08/22 | 16:00:05 | 11 Aug 2022 | | Share Incentive Plan - Director/PDMR Shareholding |
| 01/08/22 | 17:30:01 | 1 Aug 2022 | | Issue of Equity and Total Voting Rights |
| 12/07/22 | 17:00:06 | 12 Jul 2022 | | Share Incentive Plan - Director/PDMR Shareholding |
| 11/07/22 | 07:00:05 | 11 Jul 2022 | | Sale and leaseback of headquarters building |
